- Home
- DAC vs ELVN Comparison
DAC vs ELVN Comparison
Compare DAC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAC | ELVN |
|---|---|---|
| Founded | 1972 | 2016 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DAC | ELVN |
|---|---|---|
| Price | $132.42 | $42.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $112.50 | $43.40 |
| AVG Volume (30 Days) | 73.0K | ★ 635.1K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $82.75 | $14.79 |
| 52 Week High | $135.21 | $48.53 |
Technical Indicators
Market Signals| Indicator | DAC | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 70.92 | 54.33 |
| Support Level | $91.64 | $16.84 |
| Resistance Level | N/A | $48.53 |
| Average True Range (ATR) | 3.52 | 2.28 |
| MACD | 1.25 | -0.68 |
| Stochastic Oscillator | 86.41 | 41.37 |
Price Performance
Historical ComparisonAbout DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.